MRD / Regn No. : 20260000056 Date : 23/06/2026
Patient Name : Srabani Chatterjee Age & Gender : 55 Yrs. / Female
Contact No. : 8617097442 UHID :
Ht / Wt / BMI : 157 / 73.8 / 29.94 BP S / BP D : /
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DM (30/Jan/2026) | MASLD (11/Feb/2026) |
Subjective : TYPE 2 DM FROM 2015,DYSSOMNIA
Objective : NONE
Analysis : TYPE 2 DM,OBESITY,INCREASE FIB4 SCORE,MASLD
Plan : DECREASE INSULIN TO 16 UNITS,CHANGE INSULIN TO ONCE DAILY,SEE ME IN 2 MONTHS WITH TESTING  
Salient Investigations : FASTING PLASMA GLUCOSE (FPG): 86.5 mg/dL | GLYCOSYLATED HEMOGLOBIN (HBA1C): 6.7 % | POST PRANDIAL GLUCOSE (2HPP): 162 mg/dL
S# Generic (Trade) Name Route Dosage Usage Duration
1 INJECTION DEGLUDEC / ASPART (INJ U100) 70/30
RYZODEG
Medicine For DIABETES
SQ 0-16-0 UNITS BEFORE FOOD
TILL NEXT VISIT
MAY CAUSE HYPOGLYCEMIA
2 SGLT2I EMPAGLIFLOZIN 10 MG
JARDIANCE
Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION
PO 1-0-0 BEFORE FOOD
TILL NEXT VISIT
MAY CAUSE GENITOURINARY INFECTIONS
3 ROSUVASTATIN 10 MG
ROSEDAY 10 MG
Medicine For CHOLESTEROL
PO 0-0-1 AT BEDTIME
TILL NEXT VISIT
MAY CAUSE FATIGUE AND MUSCLE PAIN
4 PIOZ 7.5 MG
PIOGLITAZONE 7.5 MG
1-0-0 BEFORE FOOD
TILL NEXT VISIT
MAY CAUSE SWELLING IN THE FEET
5 INJECTION SEMAGLUTIDE 1 MG
SEMALIX 1 MG
Medicine For DIABETES OBESITY
SQ ONCE A WEEK AS DIRECTED NO RELATION TO MEALS
TILL NEXT VISIT
MAY CAUSE VOMITING NAUSEA OR DIARRHEA
       
Refill : 0 / Substitution:    
Education :
Next Visit : 22/Aug/2026
Tests Suggested For Next Visit : DEXA SPINE L HIP,FBS 2HPP
   
   

Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu / 48748 HPRID: 71-0638-2075-7542

Disclaimer: This is an ONLINE consultation. The patient has not been physically examined. The prescription or advice is based on the patient's description of the problem which is given above and also explained over video consultation.
This is a Computer generated Prescription

Powered By: